Treace Medical Concepts, Inc. (TMCI) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts TMCI Hot Sheet
Join SI Premium – FREE
Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q2 EPS of ($0.24), $0.06 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $45.4 million versus the consensus estimate of $43.94 million.
For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nike (NKE) Tops Q1 EPS by 4c
- Amentum wins $79M contract for helicopter maintenance at Andrews
- ChronoScale targets $1B revenue run rate with new AI deals
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
